Menstrual Health

Women’s Health DTC Platform Unfabled Launches Consumer Insights Platform; Introduces New Range of Signature Supplements

UK-based women’s health and wellbeing platform Unfabled is launching Unfabled Labs, a new consumer insights and research platform aimed at driving innovation in the women’s health and wellbeing industry. The platform will leverage data from over 400,000 women and non-binary individuals to support the development of new products and services tailored to their specific health needs. “Significantly increasing the safe collection of…

TiumBio Shares Positive Phase 2a Trial Results for Merigolix in Endometriosis Treatment Following $12M Funding Round

TiumBio, a clinical-stage biopharmaceutical company based in South Korea, recently unveiled encouraging findings from its Phase 2a clinical trial of Merigolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, aimed at alleviating moderate to severe endometriosis-associated pain. This announcement comes on the heels of a successful $12 million funding round, earmarked to advance the company’s clinical pipeline. The Phase 2a trial showcased promising…

Samphire Neuroscience Raises $2.3M in Pre-seed Funding for Novel Neurotechnology Wearable Targeting PMS & Menstrual Pain

Samphire Neuroscience, a medtech startup, has announced a successful $2.3 million pre-seed funding round for its pioneering neurotechnology wearable, Nettle. Designed to manage premenstrual syndrome (PMS) and menstrual pain, Nettle represents a significant step forward in at-home neurostimulation treatment. With over 90% of women affected by menstrual pain and PMS at some point, the demand for such solutions is evident. The funding…

Essence App Secures $600K to Transform Menstrual Health Support in Workplaces

The Essence App, focused on improving workplace environments for women and individuals with menstrual cycles, has completed a $600K funding round. Participants in the round include Berkeley SkyDeck Fund, Davidovs VC, Growing Well Partners, and notable angel investors like Eugenia Dunaeva and Ksenia Kapoor, among others. This financial boost aims to refine the app’s capabilities, broaden its customer base, and explore the…

Diva’Me Raises $1M Pre-Seed Funding to Advance Menstrual Health in Dubai and Beyond

Diva’Me, a femtech company co-founded by Prashant and Nadine Audi, has raised $1 million in pre-seed funding led by Verde. Based in Dubai, the company is committed to revolutionizing women’s health by advancing societal norms surrounding menstruation and offering innovative, technology-driven solutions. Central to Diva’Me’s mission is the development of an AI-based personalized counseling app. This forthcoming app is designed to connect…

The Diagnostic Potential of Menstrual Blood

Wow wow wow. We really started the year with a bit of a bang 💥 in women’s health last week: In a somewhat historic advancement for women’s health, Qvin’s received FDA approval of the Q-Pad, an innovative menstrual blood-based health monitoring pad. Qvin’s FDA approval last week was more then just a news story, it’s really a narrative shift, positioning menstrual blood at the very center…

Qvin’s Q-Pad Makes History with First FDA Approval for Menstrual Blood Health Testing

Biotech research company Qvin has announced the FDA clearance of its innovative Q-Pad and A1c Test, marking a significant advancement in women’s health technology. This approval introduces a new method of health monitoring for millions of American women, particularly those living with diabetes, through menstrual blood testing. The Q-Pad offers a less invasive and more accessible alternative to traditional venous blood draws.…

Clue Partners with Universities to Research and Address Female Health Diagnosis Gap

Clue, a femtech and reproductive health platform, has recently announced a new initiative in collaboration with top global universities, including the University of California, Berkeley, and the University of Exeter, along with the Menarche Menstruation Menopause and Mental Health (4M) consortium. The initiative aims to use anonymized health data from Clue users to close the diagnosis gap for female health conditions. This…